Prevention Meds, Inc. – Trademark Portfolio

Entity Type: 03

Prevention Meds, Inc. holds 27 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 26 filings in this category. The portfolio also extends into Class 38 (Telecommunications) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include PRECREA, PRELIPID, and PREMENORA. The owner is based in Lebanon, NJ.

3 Saxton Lane

Lebanon, NJ 08833

27 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Page 1 of 2 (27 results)

Trademark Classifications

Prevention Meds, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (26 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

38
Telecommunications (1 filing)

Telecommunications

Frequently Asked Questions

How many trademarks does Prevention Meds, Inc. have?

Prevention Meds, Inc. has 27 U.S. trademarks filed with the USPTO. Of these, 3 registered, 13 abandoned, 11 cancelled.

What trademark classes does Prevention Meds, Inc. file in?

Prevention Meds, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 38 (Telecommunications). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Prevention Meds, Inc.'s most well-known trademarks?

Prevention Meds, Inc.'s registered trademark portfolio includes well-known marks such as PRECREA, PRELIPID, and PREMENORA. These are among 3 currently registered trademarks in the portfolio.

What is Prevention Meds, Inc.'s trademark registration success rate?

Prevention Meds, Inc. has a 11% trademark registration rate, with 3 out of 27 resolved applications resulting in successful registration. Currently, 0 applications are pending review.